{"id":"eprazinone","rwe":[],"tags":[{"label":"eprazinone","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"R05CB04","category":"atc"},{"label":"Active","category":"status"},{"label":"Expectorants","category":"pharmacology"},{"label":"Respiratory System Agents","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["eprazinone hydrochloride","eprazinone","eprazinone HCl"],"offLabel":[],"synonyms":["eprazinone hydrochloride","eprazinone","eprazinone HCl"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"eprazinone","explanation":"Imagine your body's cells are like locks, and eprazinone is a key that fits into one of those locks. When it binds to the lock, it can either turn it on or off, depending on the type of lock and the key's shape. However, since eprazinone's target is unknown, we can't say exactly how it works or what it does.","oneSentence":"Eprazinone is a small molecule that works by interacting with a specific target in the body, but its exact mechanism is unknown.","technicalDetail":"Eprazinone's mechanism of action is not well understood, but it is believed to interact with a specific protein or receptor in the body, potentially altering its activity or expression."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1035","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=EPRAZINONE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:04:05.383169","biosimilars":[],"competitors":[{"drugName":"acetylcysteine","drugSlug":"acetylcysteine","fdaApproval":"1963-09-14","patentExpiry":"May 8, 2032","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"mesna","drugSlug":"mesna","fdaApproval":"1988-12-30","genericCount":9,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"dornase alfa","drugSlug":"dornase-alfa","fdaApproval":"1993-12-30","relationship":"same-class"},{"drugName":"mannitol","drugSlug":"mannitol","fdaApproval":"1964-06-08","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"eprazinone","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"acetylcysteine","brandName":"acetylcysteine","genericName":"acetylcysteine","approvalYear":"1963","relationship":"same-class"},{"drugId":"mesna","brandName":"mesna","genericName":"mesna","approvalYear":"1988","relationship":"same-class"},{"drugId":"dornase-alfa","brandName":"dornase alfa","genericName":"dornase alfa","approvalYear":"1993","relationship":"same-class"},{"drugId":"mannitol","brandName":"mannitol","genericName":"mannitol","approvalYear":"1964","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"005621","UNII":"883YNL63WU","CHEBI":"CHEBI:82716","INN_ID":"2745","RXNORM":"236310","UMLSCUI":"C0059469","ChEMBL_ID":"CHEMBL1885437","KEGG_DRUG":"D01106","DRUGBANK_ID":"DB08990","PUBCHEM_CID":"3245","SNOMEDCT_US":"708830003","SECONDARY_CAS_RN":"10402-53-6","MESH_SUPPLEMENTAL_RECORD_UI":"C007608"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":17,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"R05CB04","allCodes":["R05CB04"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"EPRAZINONE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Eprazinone is a small molecule drug of the eprazinone class, but its target and mechanism of action are unknown. It is not clear if it has been approved by the FDA or if it is commercially available. Eprazinone's indications, half-life, bioavailability, and generic manufacturers are also unknown. As a result, its commercial status and key safety considerations cannot be determined. Further research is needed to understand this drug's properties and potential uses.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}